- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -1.26%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option and its peers as on 1 September, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 16.36% | -1.26% | 0.82% | 1.45% | 11.06% | 13.39% | 18.72% | - | - | - |
| SBI MNC FUND - REGULAR PLAN -GROWTH | 18.36% | -0.65% | 0.39% | 3.16% | 12.3% | 17.7% | 7.88% | 8.46% | 14.49% | 11.28% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 24.05% | -0.97% | 0.62% | 1.74% | 14.42% | 21.8% | 23.77% | 17.45% | 24.86% | 13.83% |
| SBI COMMA Fund - REGULAR PLAN - Growth | 7.06% | 0.01% | 0.38% | 1.99% | 1.43% | 15.19% | 16.26% | 11.33% | 19.93% | 15.05% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -2.73% | -1.03% | -0.99% | -0.66% | 5.03% | 1.5% | 9.62% | 8.35% | 13.01% | 11.07% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | 0.35% | 0.1% | -2.14% | -2.9% | -1.18% | 4.27% | 13.61% | 15.95% | 19.39% | 14.37% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | -8.89% | 32.42% | 41.76% | -10.78% |
Discrete returns (monthly)
| Month | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.19% | -2.59% | -6.96% | 6.8% | -4.76% | 7.57% | 2.95% | 5.81% | 3.87% | 2.74% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 3.92% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 97.89% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 2.11% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 13.26% | |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 7.97% | |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.05% | |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.05% | |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.84% | |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.43% | |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.41% | |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 4.21% | |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 3.84% | |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.39% | |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 3.04% | |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 3.03% | |
| Global Health Limited | MEDANTA (INE474Q01031) | Healthcare Services | 2.98% | |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.92% | |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.82% | |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.79% | |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 1.90% | |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 1.52% | |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.50% | |
| Aster DM Quality Care Limited | ASTERDM (INE914M01019) | Healthcare Services | 1.35% | |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.32% | |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.27% | |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 1.23% | |
| Healthcare Global Enterprises Limited | HCG (INE075I01017) | Healthcare Services | 1.21% | |
| Shilpa Medicare Limited | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 1.15% | |
| Linde India Limited | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 1.10% | |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 1.09% | |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 1.05% | |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.95% | |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.93% | |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.92% | |
| MedPlus Health Services Limited | MEDPLUS (INE804L01022) | Retailing | 0.88% | |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.72% | |
| Venus Pipes And Tubes Limited | VENUSPIPES (INE0JA001018) | Industrial Products | 0.69% | |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.61% | |
| Caplin Point Laboratories Limited | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 0.54% | |
| Bharat Dynamics Limited | BDL (INE171Z01026) | Aerospace & Defense | 0.47% | |
| Yes Bank Limited | YESBANK (INE528G01035) | Banks | 0.46% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 July, 2026
NAV history
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 1 September, 2026 | 18.2022 | -1.26% |
| 31 August, 2026 | 18.4347 | 0.87% |
| 28 August, 2026 | 18.2748 | 0.24% |
| 27 August, 2026 | 18.2303 | 0.59% |
| 26 August, 2026 | 18.1238 | 0.39% |
| 25 August, 2026 | 18.0538 | 0.8% |
| 24 August, 2026 | 17.9108 | -0.21% |
| 21 August, 2026 | 17.9481 | -0.43% |
| 20 August, 2026 | 18.0249 | 0.31% |
| 19 August, 2026 | 17.9694 | -0.34% |
| 18 August, 2026 | 18.0301 | 0.38% |
| 17 August, 2026 | 17.9611 | -0.37% |
| 14 August, 2026 | 18.0274 | -0.32% |
| 13 August, 2026 | 18.0850 | -0.23% |
| 12 August, 2026 | 18.1271 | -0.81% |
| 11 August, 2026 | 18.2753 | 0.46% |
| 10 August, 2026 | 18.1920 | 0.08% |
| 7 August, 2026 | 18.1778 | 0.39% |
| 6 August, 2026 | 18.1067 | 0.39% |
| 5 August, 2026 | 18.0362 | 0.15% |
| 4 August, 2026 | 18.0094 | -0.11% |
| 3 August, 2026 | 18.0295 | 0.49% |
| 31 July, 2026 | 17.9422 | 0.24% |
| 30 July, 2026 | 17.8998 | -0.14% |
| 29 July, 2026 | 17.9255 | 1.23% |
| 28 July, 2026 | 17.7079 | 0.05% |
| 27 July, 2026 | 17.6990 | 1.59% |
| 24 July, 2026 | 17.4219 | -0.24% |
| 23 July, 2026 | 17.4635 | -0.42% |
| 22 July, 2026 | 17.5368 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 18.2022 as on 1 September, 2026.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 16.36% as on 1 September, 2026.What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 13.39% as on 1 September, 2026.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 18.72% as on 1 September, 2026.What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.